%A HUANG Ling-Xiao, YAO Wen-Xiu %T Her2 gene and breast cancer targeted therapy %0 Journal Article %D 2014 %J Journal of International Oncology %R １０．３７６０／ｃｍａ．ｊ．ｉｓｓｎ．１６７３４２２Ｘ．２０１４．１０．０１３ %P 760-763 %V 41 %N 10 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9503.shtml} %8 2014-10-29 %X In recent years, with the development of tumor molecular biology technology, molecular targeted therapy has become a study hotspot, which plays a significant role on breast cancer treatment strategy. Among them, the human epidermal growth factor receptor2 (Her2) has been proven as an effective molecular target. So molecular targeted therapy of breast cancer become another important treatment except chemotherapy and endocrine therapy.